tykhr
sign in
free sign up
Revelation Biosciences Inc
Biotechnology
Healthcare
REVB
971 K shares
NASDAQ US
traded
23 Sep 2025
listed
no
open
1.50
52 week high
33.44
high
1.51
52 week low
0.00
low
1.44
growth
-89.12 %
previous Close
1.52
P/E ratio
-0
market cap
3.65 M
div yield
0
usd
Jun 2025
qoq
revenue
0.00 %
net incoming
0.00 %
eps
-7.01 %
-232.23 %
eps surprise
-13.98 %
net profit margin
0.00 %
0.00 %
operating incoming
0.00 %
net change in cash
0.00 %
cash on hand
0.00 %
cost of revenue
0.00 %
top